Viloxazine (Qelbree): A Faster Strattera?

On April 2, 2021, viloxazine, brand name Qelbree, received FDA approval for the treatment of ADHD in children and adolescents ages 6-17 years old. The latest issue of The Carlat Child Psychiatry Report includes a News of Note covering this newly approved medication for ADHD. In this podcast, we discuss the advantages and disadvantages of viloxazine for children and adolescents with ADHD.

https://www.thecarlatreport.com/podcast/viloxazine-qelbree-a-faster-strattera-2/

Author

Joshua Feder, M.D. Dr. Feder's Blog

You Might Also Enjoy...

How the New Autism Policy Helps Families

For years, autism care has centered on one model, but that’s changing. The American Academy of Child and Adolescent Psychiatry just redefined what evidence-based care really means. This shift could transform how we support children and families.

Podcast Dive: What Does the New AACAP Autism Policy Mean for Doctors and Families?

Helping Kids Feel Safe - Talking About School Shootings

School shootings are tragic and deeply unsettling, but they remain rare. In this podcast, we offer our thoughts on how to help children and teens who are worried about the possibility of shooting at their own schools.

Grief, Parenting, and Recovery After a Disaster

How do families respond emotionally to disaster? How do children process the death of a parent? I hope this conversation helps our listeners make informed choices and do the things they need to do to care for themselves and their communities.

Unseen and Misunderstood: Autism, Masking, and the Legal System

Autism in Teens and Adults Who Mask or Are Undiagnosed may be misunderstood in legal settings , resulting in confusion, mishandling, and unnecessary suffering and harm. Watch Dr. Feder's 30 minute v video, originally produced for public defenders.

Hidden Dangers: The Fentanyl Crisis and Teen Overdose Prevention

The Fentanyl overdose crisis is now one of the leading causes of death among adolescents, and it is happening in every corner of the country. In this podcast Dr Feder talks about the state of the crisis and the steps we can take to save lives.